Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

8.03
Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
2.20
Today|||52-Week Range
8.84
+25.27%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close8.03
Today’s open8.00
Day’s range7.83 - 8.11
Volume2,069,301
Average volume (3 months)3,206,579
Market cap$1.2B
Data as of 4:00pm ET, 01/19/2018

Growth & Valuation

Earnings growth (last year)-154.93%
Earnings growth (this year)+39.39%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-49.72%
P/E ratioNM
Price/Sales4.13
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...0.000.00%
NTLAIntellia Therapeutic...0.000.00%
MYOVMyovant Sciences Ltd0.000.00%
CRSPCRISPR Therapeutics ...0.000.00%
Data as of 4:00pm ET, 01/19/2018

Financials

Next reporting dateFebruary 16, 2018
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$43.0M
Annual profit (last year)-$157.8M
Net profit margin-366.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts